A citation-based method for searching scientific literature

Michael Limenta, Christine S C Ho, Jalene W W Poh, Su-Yen Goh, Dorothy S L Toh. Clin Drug Investig 2019
Times Cited: 10







List of co-cited articles
32 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes.
Bernard Zinman, Christoph Wanner, John M Lachin, David Fitchett, Erich Bluhmki, Stefan Hantel, Michaela Mattheus, Theresa Devins, Odd Erik Johansen, Hans J Woerle,[...]. N Engl J Med 2015
40

Euglycemic Diabetic Ketoacidosis: A Potential Complication of Treatment With Sodium-Glucose Cotransporter 2 Inhibition.
Anne L Peters, Elizabeth O Buschur, John B Buse, Pejman Cohan, Jamie C Diner, Irl B Hirsch. Diabetes Care 2015
458
30

AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY POSITION STATEMENT ON THE ASSOCIATION OF SGLT-2 INHIBITORS AND DIABETIC KETOACIDOSIS.
Yehuda Handelsman, Robert R Henry, Zachary T Bloomgarden, Sam Dagogo-Jack, Ralph A DeFronzo, Daniel Einhorn, Ele Ferrannini, Vivian A Fonseca, Alan J Garber, George Grunberger,[...]. Endocr Pract 2016
183
30

Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction.
John J V McMurray, Scott D Solomon, Silvio E Inzucchi, Lars Køber, Mikhail N Kosiborod, Felipe A Martinez, Piotr Ponikowski, Marc S Sabatine, Inder S Anand, Jan Bělohlávek,[...]. N Engl J Med 2019
20

Quantitative PCR tissue expression profiling of the human SGLT2 gene and related family members.
Jian Chen, Sandy Williams, Samantha Ho, Howard Loraine, Deborah Hagan, Jean M Whaley, John N Feder. Diabetes Ther 2010
174
20

Metabolic response to sodium-glucose cotransporter 2 inhibition in type 2 diabetic patients.
Ele Ferrannini, Elza Muscelli, Silvia Frascerra, Simona Baldi, Andrea Mari, Tim Heise, Uli C Broedl, Hans-Juergen Woerle. J Clin Invest 2014
685
20

Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy.
Vlado Perkovic, Meg J Jardine, Bruce Neal, Severine Bompoint, Hiddo J L Heerspink, David M Charytan, Robert Edwards, Rajiv Agarwal, George Bakris, Scott Bull,[...]. N Engl J Med 2019
20

Diabetic ketoacidosis precipitated by Covid-19 in a patient with newly diagnosed diabetes mellitus.
Ying Jie Chee, Shereen Jia Huey Ng, Ester Yeoh. Diabetes Res Clin Pract 2020
150
20


Euglycaemic diabetic ketoacidosis.
J F Munro, I W Campbell, A C McCuish, L J Duncan. Br Med J 1973
164
20

Trends in Diabetic Ketoacidosis Hospitalizations and In-Hospital Mortality - United States, 2000-2014.
Stephen R Benoit, Yan Zhang, Linda S Geiss, Edward W Gregg, Ann Albright. MMWR Morb Mortal Wkly Rep 2018
117
20

Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China.
Chaomin Wu, Xiaoyan Chen, Yanping Cai, Jia'an Xia, Xing Zhou, Sha Xu, Hanping Huang, Li Zhang, Xia Zhou, Chunling Du,[...]. JAMA Intern Med 2020
20

Acute Hyperglycemic Crises with Coronavirus Disease-19: Case Reports.
Na Young Kim, Eunyeong Ha, Jun Sung Moon, Yong Hoon Lee, Eun Young Choi. Diabetes Metab J 2020
55
20

DKA cases over the last three years: has anything changed?
T Stratigou, N Vallianou, B Vlassopoulou, M Tzanela, D Vassiliadi, G Ioannidis, S Tsagarakis. Diabetes Metab Syndr 2019
4
50

Binding of SARS coronavirus to its receptor damages islets and causes acute diabetes.
Jin-Kui Yang, Shan-Shan Lin, Xiu-Juan Ji, Li-Min Guo. Acta Diabetol 2010
553
20

Diabetic Ketoacidosis With Canagliflozin, a Sodium-Glucose Cotransporter 2 Inhibitor, in Patients With Type 1 Diabetes.
Anne L Peters, Robert R Henry, Payal Thakkar, Cindy Tong, Maria Alba. Diabetes Care 2016
61
20

Diabetes in COVID-19: Prevalence, pathophysiology, prognosis and practical considerations.
Awadhesh Kumar Singh, Ritesh Gupta, Amerta Ghosh, Anoop Misra. Diabetes Metab Syndr 2020
301
20

Hyperglycemic crises in adult patients with diabetes.
Abbas E Kitabchi, Guillermo E Umpierrez, John M Miles, Joseph N Fisher. Diabetes Care 2009
834
20

SGLT2 Inhibitors Increase the Risk of Diabetic Ketoacidosis Developing in the Community and During Hospital Admission.
Peter S Hamblin, Rosemary Wong, Elif I Ekinci, Spiros Fourlanos, Sonali Shah, Alicia R Jones, Matthew J L Hare, Genevieve L Calder, Dilan Seneviratne Epa, Elizabeth M George,[...]. J Clin Endocrinol Metab 2019
45
20

Management of Hyperglycemic Crises: Diabetic Ketoacidosis and Hyperglycemic Hyperosmolar State.
Maya Fayfman, Francisco J Pasquel, Guillermo E Umpierrez. Med Clin North Am 2017
69
20

Sodium-glucose cotransporter 2 inhibitors for type 2 diabetes: a systematic review and meta-analysis.
Despoina Vasilakou, Thomas Karagiannis, Eleni Athanasiadou, Maria Mainou, Aris Liakos, Eleni Bekiari, Maria Sarigianni, David R Matthews, Apostolos Tsapas. Ann Intern Med 2013
556
20

Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes.
Bruce Neal, Vlado Perkovic, Kenneth W Mahaffey, Dick de Zeeuw, Greg Fulcher, Ngozi Erondu, Wayne Shaw, Gordon Law, Mehul Desai, David R Matthews. N Engl J Med 2017
20

Ketoacidosis associated with SGLT2 inhibitor treatment: Analysis of FAERS data.
Jenny E Blau, Sri Harsha Tella, Simeon I Taylor, Kristina I Rother. Diabetes Metab Res Rev 2017
97
20

Inhibition of the glucose transporter SGLT2 with dapagliflozin in pancreatic alpha cells triggers glucagon secretion.
Caroline Bonner, Julie Kerr-Conte, Valéry Gmyr, Gurvan Queniat, Ericka Moerman, Julien Thévenet, Cédric Beaucamps, Nathalie Delalleau, Iuliana Popescu, Willy J Malaisse,[...]. Nat Med 2015
416
20



SGLT2 Inhibitor-associated Diabetic Ketoacidosis: Clinical Review and Recommendations for Prevention and Diagnosis.
Ronald M Goldenberg, Lori D Berard, Alice Y Y Cheng, Jeremy D Gilbert, Subodh Verma, Vincent C Woo, Jean-François Yale. Clin Ther 2016
126
20


Prolonged acidosis is a feature of SGLT2i-induced euglycaemic diabetic ketoacidosis.
Mohammed Faraz Rafey, Arslan Butt, Barry Coffey, Lisa Reddington, Aiden Devitt, David Lappin, Francis M Finucane. Endocrinol Diabetes Metab Case Rep 2019
14
20

Clinical characteristics of diabetic ketoacidosis in users and non-users of SGLT2 inhibitors.
J Y Jeon, S-K Kim, K-S Kim, S O Song, J-S Yun, B-Y Kim, C-H Kim, S O Park, S Hong, D H Seo,[...]. Diabetes Metab 2019
13
20



The effect of empagliflozin on arterial stiffness and heart rate variability in subjects with uncomplicated type 1 diabetes mellitus.
David Zi Cherney, Bruce A Perkins, Nima Soleymanlou, Ronnie Har, Nora Fagan, Odd Erik Johansen, Hans-Juergen Woerle, Maximilian von Eynatten, Uli C Broedl. Cardiovasc Diabetol 2014
327
10

Transcriptional regulation of NHE3 and SGLT1 by the circadian clock protein Per1 in proximal tubule cells.
Kristen Solocinski, Jacob Richards, Sean All, Kit-Yan Cheng, Syed J Khundmiri, Michelle L Gumz. Am J Physiol Renal Physiol 2015
36
10

Effect of renal tubule-specific knockdown of the Na+/H+ exchanger NHE3 in Akita diabetic mice.
Akira Onishi, Yiling Fu, Manjula Darshi, Maria Crespo-Masip, Winnie Huang, Panai Song, Rohit Patel, Young Chul Kim, Josselin Nespoux, Brent Freeman,[...]. Am J Physiol Renal Physiol 2019
30
10

Nitric oxide synthase in macula densa regulates glomerular capillary pressure.
C S Wilcox, W J Welch, F Murad, S S Gross, G Taylor, R Levi, H H Schmidt. Proc Natl Acad Sci U S A 1992
487
10


Dapagliflozin a glucose-regulating drug with diuretic properties in subjects with type 2 diabetes.
H J Lambers Heerspink, D de Zeeuw, L Wie, B Leslie, J List. Diabetes Obes Metab 2013
485
10

Acute Pharmacodynamic Effects of Empagliflozin With and Without Diuretic Agents in Patients With Type 2 Diabetes Mellitus.
Tim Heise, Jens Jordan, Christoph Wanner, Martina Heer, Sreeraj Macha, Michaela Mattheus, Søren S Lund, Hans J Woerle, Uli C Broedl. Clin Ther 2016
33
10

Renal protective effect of SGLT2 inhibitor dapagliflozin alone and in combination with irbesartan in a rat model of diabetic nephropathy.
Ali F Abdel-Wahab, Ghazi A Bamagous, Randa M Al-Harizy, Naser A ElSawy, Naiyer Shahzad, Ibrahim A Ibrahim, Saeed S Al Ghamdi. Biomed Pharmacother 2018
24
10

Effects of canagliflozin on body weight and relationship to HbA1c and blood pressure changes in patients with type 2 diabetes.
William T Cefalu, Kaj Stenlöf, Lawrence A Leiter, John P H Wilding, Lawrence Blonde, David Polidori, John Xie, Daniel Sullivan, Keith Usiskin, William Canovatchel,[...]. Diabetologia 2015
85
10

Hemoglobin mass and intravascular volume kinetics during and after exposure to 3,454-m altitude.
C Siebenmann, A Cathomen, M Hug, S Keiser, A K Lundby, M P Hilty, J P Goetze, P Rasmussen, C Lundby. J Appl Physiol (1985) 2015
71
10

Renal olfactory receptor 1393 contributes to the progression of type 2 diabetes in a diet-induced obesity model.
Blythe D Shepard, Hermann Koepsell, Jennifer L Pluznick. Am J Physiol Renal Physiol 2019
17
10

Hypertension as a Metabolic Disorder and the Novel Role of the Gut.
Masami Tanaka, Hiroshi Itoh. Curr Hypertens Rep 2019
45
10

Sodium-glucose cotransporter 2 inhibitors and inflammation in chronic kidney disease: Possible molecular pathways.
Habib Yaribeygi, Alexandra E Butler, Stephen L Atkin, Niki Katsiki, Amirhossein Sahebkar. J Cell Physiol 2018
56
10

Association between Blood Viscosity and Cardiovascular Risk Factors in Patients with Arterial Hypertension in a High Altitude Setting.
Erika D Taco-Vasquez, Francisco Barrera, Marcos Serrano-Duenas, Enoe Jimenez, Alexander Rocuts, Efrain Riveros Perez. Cureus 2019
8
12

Renal hemodynamic effect of sodium-glucose cotransporter 2 inhibition in patients with type 1 diabetes mellitus.
David Z I Cherney, Bruce A Perkins, Nima Soleymanlou, Maria Maione, Vesta Lai, Alana Lee, Nora M Fagan, Hans J Woerle, Odd Erik Johansen, Uli C Broedl,[...]. Circulation 2014
802
10

Macula Densa SGLT1-NOS1-Tubuloglomerular Feedback Pathway, a New Mechanism for Glomerular Hyperfiltration during Hyperglycemia.
Jie Zhang, Jin Wei, Shan Jiang, Lan Xu, Lei Wang, Feng Cheng, Jacentha Buggs, Hermann Koepsell, Volker Vallon, Ruisheng Liu. J Am Soc Nephrol 2019
46
10

The Effects of Sodium-Glucose Cotransporter 2 Inhibitors on Sympathetic Nervous Activity.
Ningning Wan, Asadur Rahman, Hirofumi Hitomi, Akira Nishiyama. Front Endocrinol (Lausanne) 2018
53
10

Localizations of Na(+)-D-glucose cotransporters SGLT1 and SGLT2 in human kidney and of SGLT1 in human small intestine, liver, lung, and heart.
Ivana Vrhovac, Daniela Balen Eror, Dirk Klessen, Christa Burger, Davorka Breljak, Ognjen Kraus, Nikola Radović, Stipe Jadrijević, Ivan Aleksic, Thorsten Walles,[...]. Pflugers Arch 2015
166
10


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.